CVS Health Corporation (CVS)
NYSE · Healthcare
CVS Health Corporation EBITDA 2007–2025
CVS Health Corporation annual/quarterly ebitda history and growth rate from 2007 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- CVS Health Corporation ebitda for the quarter ending March 31, 2026 was 5.8 B, a 27.98% increase year-over-year.
- CVS Health Corporation ebitda for the twelve months ending March 31, 2026 was 11.8 B, a 15.97% decrease year-over-year.
- CVS Health Corporation annual ebitda for 2025 was 9.3 B, a 29.34% decrease from 2024.
- CVS Health Corporation annual ebitda for 2024 was 13.1 B, a 27.59% decrease from 2023.
- CVS Health Corporation annual ebitda for 2023 was 18.1 B, a 48.70% increase from 2022.
- CVS Health Corporation annual ebitda for 2022 was 12.2 B.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
CVS Health Corporation EBITDA — FAQ
CVS Health Corporation (CVS) ebitda over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CVS's ebitda history?
The chart and table above show CVS Health Corporation's ebitda by year and by quarter, including the growth rate.